Metabolon Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Metabolon Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010931
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metabolon Inc (Metabolon) is a health technology company that develops clinical diagnostic tests for healthcare markets. The company’s products include non-alcoholic steatohepatitis test, GFR test, quantose IGT test, prostarix and prostarix plus tests, among others. Its quantose IR test is a blood test performed for detecting early-stage insulin resistance and for obesity related chronic diseases. Metabolon provides metabolomics services for various applications in the areas of research in discovery biology, pharmaceutical research and development, clinical trials, nutrition and consumer goods, and bioprocessing and cell culture science. The company collaborates with research institutions, pharmaceutical, nutrition, agricultural and consumer goods companies for its research activities. It has operations in the UK and the US. Metabolon is headquartered in Durham, North Carolina, the US.

Metabolon Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metabolon Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Metabolon Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Metabolon Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Metabolon Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Metabolon Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Metabolon Raises USD15 Million in Venture Financing 11
Metabolon Raises USD5 Million in Venture Financing 12
Metabolon Raises US$15 Million In Series E Financing 13
Metabolon Secures US$13 Million In Series D Financing 15
Private Equity 16
Essex Woodlands Management Invests Additional USD15 Million in Metabolon 16
Partnerships 17
Zhejiang Dian Diagnostics Enters into Licensing Agreement with Metabolon 17
Metabolon Enters into Licensing Agreement with Synlab 18
Muses Labs Partners with Metabolon 19
Metabolon Enters into Co-Development Agreement with Johns Hopkins University and Tufts Medical Center 20
Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 21
Global Genomics Enters Into Agreement With Metabolon For Cardiovascular Disease Biomarkers And Drug Targets 22
Metabolon And Bostwick Lab Enter Into Agreement To Market Prostarix Test 23
Imdea Food Enters Into Agreement With Metabolon To Advance Nutrition-Based Personalized Medicine 24
Metabolon Enters Into Co-Development Agreement With Takeda Pharma 25
Metabolon Enters Into Licensing Agreement With Patia Biopharma For Quantose Prediabetes Test 26
Acquisition 27
Metabolon Acquires Lipomics Technologies, Diagnostics Company 27
Metabolon Inc – Key Competitors 28
Metabolon Inc – Key Employees 29
Metabolon Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 30
Recent Developments 31
Corporate Communications 31
Jan 26, 2017: Metabolon Announces Changes to Executive Leadership Team 31
Other Significant Developments 32
May 03, 2017: Metabolon to Establish Metabolomics Lab in Qatar to Serve Markets in the Middle East 32
Jan 05, 2017: Metabolon to Work With InnVentis to Study Chronic Inflammatory Diseases 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Metabolon Inc, Medical Equipment, Key Facts 2
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Metabolon Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Metabolon Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Metabolon Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Metabolon Inc, Deals By Market, 2011 to YTD 2017 8
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Metabolon Raises USD15 Million in Venture Financing 11
Metabolon Raises USD5 Million in Venture Financing 12
Metabolon Raises US$15 Million In Series E Financing 13
Metabolon Secures US$13 Million In Series D Financing 15
Essex Woodlands Management Invests Additional USD15 Million in Metabolon 16
Zhejiang Dian Diagnostics Enters into Licensing Agreement with Metabolon 17
Metabolon Enters into Licensing Agreement with Synlab 18
Muses Labs Partners with Metabolon 19
Metabolon Enters into Co-Development Agreement with Johns Hopkins University and Tufts Medical Center 20
Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 21
Global Genomics Enters Into Agreement With Metabolon For Cardiovascular Disease Biomarkers And Drug Targets 22
Metabolon And Bostwick Lab Enter Into Agreement To Market Prostarix Test 23
Imdea Food Enters Into Agreement With Metabolon To Advance Nutrition-Based Personalized Medicine 24
Metabolon Enters Into Co-Development Agreement With Takeda Pharma 25
Metabolon Enters Into Licensing Agreement With Patia Biopharma For Quantose Prediabetes Test 26
Metabolon Acquires Lipomics Technologies, Diagnostics Company 27
Metabolon Inc, Key Competitors 28
Metabolon Inc, Key Employees 29
Metabolon Inc, Other Locations 30
Metabolon Inc, Subsidiaries 30
Metabolon Inc, Joint Venture 30

★海外企業調査レポート[Metabolon Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Electricity Generating Public Co Ltd:企業の発電所・SWOT分析2018
    Electricity Generating Public Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Shuttle Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Shuttle Pharmaceuticals Inc (Shuttle), formerly Shuttle Pharmaceuticals LLC is a developer of therapies that offers novel drugs for improving cancer treatment outcomes. The company’s pipeline products comprise therapies such as SP-2-001, SP-1-161, SP-1-003 and SP-3-001. Its therapies are use …
  • The Taiko Bank Ltd:企業の戦略・SWOT・財務情報
    The Taiko Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Taiko Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nippon Express Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Express Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Express Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …
  • U.S. Army Institute of Surgical Research:医療機器:M&Aディール及び事業提携情報
    Summary U.S. Army Institute of Surgical Research (USAISR), a subsidiary of U.S. Army, is a medical research center that offers solutions for burn, trauma, and combat casualty care from time of injury to rehabilitation. The center conducts research in the areas of dental and trauma research detachmen …
  • PetroTal Corp (TAL):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroTal Corp (PetroTal), formerly known as Sterling Resources Ltd, is an oil and gas company that offers exploration, development and production of crude oil and natural gas properties. The company primarily operates in Bretana oil field in Peru, South America. PetroTal has operations in th …
  • Clinipace Worldwide Inc-医療機器分野:企業M&A・提携分析
    Summary Clinipace Worldwide Inc (Clinipace) is a contract research company that offers drug and medical devices development services. The company’s services include biostatistics, clinical monitory, chemistry, manufacturing and control, data management, GCP training, global study feasibility, medica …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • MedDay SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedDay SA (MedDay) is a biotechnology company that develops drugs for nervous system disorders. The company provides clinical and pharmaceutical development in the field of rare inborn errors of metabolism to treat elucidation of metabolism pathways in the brain. Its pipeline products compri …
  • Solvay SA (SOLB):電力:M&Aディール及び事業提携情報
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates. In addition, the company manufactures additives, engineering plastics, diphenols an …
  • Mesa Air Group, Inc.:企業の戦略・SWOT・財務分析
    Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • University of Leicester-製薬・医療分野:企業M&A・提携分析
    Summary University of Leicester (UOL) is an educational service provider that offers undergraduate, postgraduate, distance learning and part-time programs. The university offers educational and research services in various disciplines such as mathematics, biochemistry, medicine, astrophysics, geneti …
  • Xylem Inc (XYL)-エネルギー分野:企業M&A・提携分析
    Summary Xylem Inc. (Xylem) is a water technology company that designs, manufactures, and service engineered technologies for water industry. The company’s products portfolio includes testing equipment; filtration, disinfection and biological treatment equipment; controls and systems; and water and w …
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務情報
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory ser …
  • Beijing Beilu Pharmaceutical Co Ltd (300016):製薬・医療:M&Aディール及び事業提携情報
    Summary Beijing Beilu Pharmaceutical Co Ltd (Beijing BeiLu) is a manufacturer of traditional Chinese medicine preparation and psychiatric products. The company provides product portfolio such as contrast media products, anti anxiety medicines and oral antihyperglycemic agents, among others. Its cont …
  • China Power Clean Energy Development Co Ltd (0735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (0735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • TerSera Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TerSera Therapeutics LLC (TerSera Therapeutics) is a pharmaceutical company that develops of specialty pharmaceutical products. The company offers ergotamine tartrate sublingual tablets, goserelin acetate implant, zoladex, and zoladex la. It develops products in the therapeutic areas of alle …
  • Euro Disney S.C.A.:戦略・SWOT・企業財務分析
    Euro Disney S.C.A. - Strategy, SWOT and Corporate Finance Report Summary Euro Disney S.C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆